In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Sabra Healthcare REIT Inc (NASDAQ: SBRA) closed at $17.9 down -1.32% from its previous closing price of $18.14. In other words, the price has decreased by -$1.32 from its previous closing price. On the day, 4.25 million shares were traded. SBRA stock price reached its highest trading level at $18.16 during the session, while it also had its lowest trading level at $17.715.
Ratios:
For a deeper understanding of Sabra Healthcare REIT Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 42.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.67. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 0.89. In the meantime, Its Debt-to-Equity ratio is 0.93 whereas as Long-Term Debt/Eq ratio is at 0.92.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on October 01, 2025, initiated with a Neutral rating and assigned the stock a target price of $20.
JMP Securities Upgraded its Mkt Perform to Mkt Outperform on January 07, 2025, while the target price for the stock was maintained at $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 20 ’25 when FOSTER MICHAEL J sold 11,000 shares for $18.22 per share. The transaction valued at 200,376 led to the insider holds 64,725 shares of the business.
Michael J. Foster bought 11,000 shares of SBRA for $192,500 on May 15 ’25. On Feb 24 ’25, another insider, Cusack Catherine, who serves as the Director of the company, bought 1,500 shares for $15.92 each. As a result, the insider paid 23,880 and bolstered with 60,583 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBRA now has a Market Capitalization of 4292279808 and an Enterprise Value of 6679511040. As of this moment, Sabra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.54, and their Forward P/E ratio for the next fiscal year is 22.31. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.92 while its Price-to-Book (P/B) ratio in mrq is 1.58. Its current Enterprise Value per Revenue stands at 9.1 whereas that against EBITDA is 15.175.
Stock Price History:
The Beta on a monthly basis for SBRA is 0.82, which has changed by 0.00055897236 over the last 52 weeks, in comparison to a change of 0.1719923 over the same period for the S&P500. Over the past 52 weeks, SBRA has reached a high of $19.99, while it has fallen to a 52-week low of $15.60. The 50-Day Moving Average of the stock is -4.53%, while the 200-Day Moving Average is calculated to be 0.83%.
Shares Statistics:
For the past three months, SBRA has traded an average of 2.43M shares per day and 2660130 over the past ten days. A total of 239.79M shares are outstanding, with a floating share count of 235.36M. Insiders hold about 1.85% of the company’s shares, while institutions hold 98.82% stake in the company. Shares short for SBRA as of 1757894400 were 19648320 with a Short Ratio of 8.07, compared to 1755216000 on 18066408. Therefore, it implies a Short% of Shares Outstanding of 19648320 and a Short% of Float of 11.540000000000001.
Dividends & Splits
According to the company, the forward annual dividend rate for SBRA is 1.17, from 1.2 in the trailing year. Against a Trailing Annual Dividend Yield of 0.066152155. The stock’s 5-year Average Dividend Yield is 8.15. The current Payout Ratio is 223.55% for SBRA, which recently paid a dividend on 2025-08-15 with an ex-dividend date of 2025-08-15. Stock splits for the company last occurred on 2010-11-16 when the company split stock in a 1:3 ratio.
Earnings Estimates
At present, 3.0 analysts are actively evaluating the performance of Sabra Healthcare REIT Inc (SBRA) in the stock market.The consensus estimate for the next quarter is $0.19, with high estimates of $0.2 and low estimates of $0.18.
Analysts are recommending an EPS of between $0.8 and $0.8 for the fiscal current year, implying an average EPS of $0.8. EPS for the following year is $0.81, with 3.0 analysts recommending between $0.83 and $0.8.
Revenue Estimates
A total of 5 analysts believe the company’s revenue will be $191.3M this quarter.It ranges from a high estimate of $198.08M to a low estimate of $182.77M. As of. The current estimate, Sabra Healthcare REIT Inc’s year-ago sales were $178MFor the next quarter, 5 analysts are estimating revenue of $196.4M. There is a high estimate of $210.91M for the next quarter, whereas the lowest estimate is $186.96M.
A total of 5 analysts have provided revenue estimates for SBRA’s current fiscal year. The highest revenue estimate was $781.68M, while the lowest revenue estimate was $722.03M, resulting in an average revenue estimate of $756.32M. In the same quarter a year ago, actual revenue was $703.24MBased on 6 analysts’ estimates, the company’s revenue will be $817M in the next fiscal year. The high estimate is $952.72M and the low estimate is $736.47M.
